Replies to post #120695 on Anavex Life Sciences Corp (AVXL)

[Amatuer17]

After one year - we are still in data analysis phase with Ariana and there is no indication of start date of Alz P2/3.

So no pk/pd data, no actual update on start date for P2/3, not trial protocol filing, no other trials started and no real update of progress - even for small biotechs, this is serious delays in company progress.

Saying that the start of trial is delayed because of cures act is also misplaced as details behind it have not been known fully in Oct last year